The American Society for Microbiology (ASM) has announced the launch of the COVID-19 Research Registry, a platform that provides timely access to top COVID-19 research vetted by experts.
Dr. Stefano Bertuzzi, CEO, ASM, notes that the next important step in response to SARS-CoV-2 is to curate and vet fundamental research on this novel coronavirus to encourage rapid scientific discovery and innovation and increase chances of defeating the virus and ending the pandemic. This curated database will ensure that scientists have an efficient way to find the timeliest and most valuable SARS-CoV-2/COVID-19 research from the latest journal articles and preprints.
The urgent nature of the SARS-CoV-2 pandemic has required the ASM to address various challenges that have surfaced during this crisis. As leaders in the microbial sciences, ASM has worked on multiple fronts to share factual, timely information on the novel coronavirus, advocate for expedited and widespread SARS-CoV-2 testing, and provide free access to research articles published over the past year in our scholarly journals.
Dr. Lynn Enquist, Henry L. Hillman Professor in Molecular Biology, Princeton University and former ASM President, will serve as Chief Curator for this project. Assistant Curators-in-Chief include:
Dr. Rozanne M. Sandri-Goldin, Chancellor's Professor, Microbiology & Molecular Genetics, University of California, Irvine, and Editor-in-Chief of ASM’s Journal of Virology; and Dr. Vaughn Cooper, Professor, Microbiology & Molecular Genetics, University of Pittsburgh, who is a current ASM Board member.
To submit research for inclusion in the COVID-19 Research Registry, authors/researchers may email [email protected].